Indication
Upper respiratory infection due to Neisseria meningitidis
An upper respiratory infection due to *Neisseria meningitidis* is a localized bacterial infection of the nasopharynx or upper respiratory tract caused by the Gram-negative diplococcus *Neisseria meningitidis*. Read more about Upper respiratory infection due to Neisseria meningitidis
15 drugs 12 manufacturers
Drugs that treat it
Common Upper respiratory infection due to Neisseria meningitidis therapies.
PENICILLIN G POTASSIUM
PFIZERPEN-G (penicillin G potassium)
PFIZERPEN-G (penicillin G potassium)
PENICILLIN G POTASSIUM
PENICILLIN G POTASSIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn upper respiratory infection due to *Neisseria meningitidis* is a localized bacterial infection of the nasopharynx or upper respiratory tract caused by the Gram-negative diplococcus *Neisseria meningitidis*.
Although the organism frequently exists as a commensal colonizer of the human nasopharyngeal mucosa, it can cause symptomatic mucosal inflammation characterized by pharyngitis, sore throat, fever, and purulent rhinitis, often serving as a prodrome in susceptible populations such as infants, adolescents, and immunocompromised individuals.
Pathophysiologically, the bacteria adhere to and invade nonciliated nasopharyngeal epithelial cells, eliciting a local inflammatory response that risks breach of the mucosal barrier and subsequent hematogenous dissemination to cause invasive meningococcal disease, including septicemia and meningitis.
- oup.com
An upper respiratory infection due to *Neisseria meningitidis* is a localized bacterial infection of the nasopharynx or upper respiratory tract caused by the Gram-negative diplococcus *Neisseria meningitidis*
- nmhealth.org
An upper respiratory infection due to *Neisseria meningitidis* is a localized bacterial infection of the nasopharynx or upper respiratory tract caused by the Gram-negative diplococcus *Neisseria meningitidis* Although the organism frequently exists as a commensal colonizer of the human nasopharyngeal mucosa, it can cause symptomatic mucosal inflammation characterized by pharyngitis, sore throat, fever, and purulent rhinitis, often serving as a prodrome in susceptible populations such as infants,...
- canada.ca
Although the organism frequently exists as a commensal colonizer of the human nasopharyngeal mucosa, it can cause symptomatic mucosal inflammation characterized by pharyngitis, sore throat, fever, and purulent rhinitis, often serving as a prodrome in susceptible populations such as infants, adolescents, and immunocompromised individuals
- nih.gov
Although the organism frequently exists as a commensal colonizer of the human nasopharyngeal mucosa, it can cause symptomatic mucosal inflammation characterized by pharyngitis, sore throat, fever, and purulent rhinitis, often serving as a prodrome in susceptible populations such as infants, adolescents, and immunocompromised individuals
- nih.gov
Although the organism frequently exists as a commensal colonizer of the human nasopharyngeal mucosa, it can cause symptomatic mucosal inflammation characterized by pharyngitis, sore throat, fever, and purulent rhinitis, often serving as a prodrome in susceptible populations such as infants, adolescents, and immunocompromised individuals Pathophysiologically, the bacteria adhere to and invade nonciliated nasopharyngeal epithelial cells, eliciting a local inflammatory response that risks breach of...
- ny.gov
Although the organism frequently exists as a commensal colonizer of the human nasopharyngeal mucosa, it can cause symptomatic mucosal inflammation characterized by pharyngitis, sore throat, fever, and purulent rhinitis, often serving as a prodrome in susceptible populations such as infants, adolescents, and immunocompromised individuals
- cdc.gov
Pathophysiologically, the bacteria adhere to and invade nonciliated nasopharyngeal epithelial cells, eliciting a local inflammatory response that risks breach of the mucosal barrier and subsequent hematogenous dissemination to cause invasive meningococcal disease, including septicemia and meningitis
Personalize your experience
Follow Upper respiratory infection due to Neisseria meningitidis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.